ProShare Advisors’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
19,775
+4,570
| +30% | +$23.4K | ﹤0.01% | 1875 |
|
|
2025
Q1 | $20.8K | Sell |
15,205
-3,319
| -18% | -$4.55K | ﹤0.01% | 2035 |
|
|
2024
Q4 | $57.2K | Buy |
18,524
+3,178
| +21% | +$9.82K | ﹤0.01% | 2162 |
|
|
2024
Q3 | $118K | Buy |
15,346
+2,772
| +22% | +$21.3K | ﹤0.01% | 1852 |
|
|
2024
Q2 | $108K | Sell |
12,574
-2,595
| -17% | -$22.3K | ﹤0.01% | 1654 |
|
|
2024
Q1 | $120K | Buy |
15,169
+1,263
| +9% | +$10K | ﹤0.01% | 1788 |
|
|
2023
Q4 | $138K | Buy |
13,906
+2,324
| +20% | +$23K | ﹤0.01% | 1728 |
|
|
2023
Q3 | $130K | Buy |
11,582
+56
| +0.5% | +$631 | ﹤0.01% | 1582 |
|
|
2023
Q2 | $38.3K | Sell |
11,526
-76
| -0.7% | -$252 | ﹤0.01% | 1796 |
|
|
2023
Q1 | $45.8K | Sell |
11,602
-1,691
| -13% | -$6.68K | ﹤0.01% | 1681 |
|
|
2022
Q4 | $96.4K | Buy |
+13,293
| New | +$96.4K | ﹤0.01% | 1657 |
|